In an interview on “How India Built Pharma Industry Against All Odds,” Manish Sabharwal, Co-Founder of TeamLease Services, breaks down the rise of India’s pharmaceutical sector. He explores how a constrained economy and a tightly regulated...
India’s ammonia rule is tightening the availability of a key raw material for pharmaceutical companies, after the government directed that surplus ammonia from urea plants be reserved primarily for fertilizer production.
India’s healthcare landscape is undergoing a remarkable transformation, driven by a new generation of MedTech startups focused on developing affordable, high-quality medical technologies. With increasing demand for accessible healthcare solutions
India is facing a serious thalassemia drug shortage, prompting the government to seek an explanation from Novartis while exploring generic alternatives to stabilize supply. The issue centers on Desferal, a life-saving treatment used by...
Eli Lilly is in advanced discussions to acquire Kelonia Therapeutics in a deal valued at more than $2 billion, signaling a strong push into next-generation cancer treatments.
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have entered into a strategic partnership to support the development and manufacturing of antibody-drug conjugates (ADCs), an emerging class of targeted cancer therap...
Indian pharma companies are witnessing a sharp drop in semaglutide API price even as demand for GLP-1 drugs surges across the country. The fall comes right after the patent expiry of semaglutide in India, which has opened the market to a wave of...
India’s radiotherapy device market is entering a high-growth phase, driven by a sharp rise in cancer cases, expanding healthcare infrastructure, and increased public investment in oncology care. Industry estimates indicate the market could more...
The Indian government has outlined a clear strategy to transform the country’s pharmaceutical sector from being the “Pharmacy of the World” — known for affordable generics — to a global leader in high-value innovations, especially biologic...
The C4 Therapeutics & Roche cancer deal has taken a major step forward as both companies expand their partnership in a move that could exceed USD 1 billion. The updated agreement strengthens their focus on developing new cancer treatments using...
.jpg)
, CDSCO.jpg)